• Health & Medicine

Early cancer diagnosis and COVID-19: unpicking the impact of the pandemic

Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future? Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future?

20 December 2022

• Health & Medicine

20 years on: how we've decreased cancer death rates

Overall, cancer death rates have decreased by 16% in the UK since we were founded. For our 20th anniversary, we're looking back at the influence and involvement we've had in reducing cancer death rates. Overall, cancer death rates have decreased by 16% in the UK since we were founded. For our 20th anniversary, we're looking back at the influence and involvement we've had in reducing cancer death rates.

17 December 2022

• For Researchers

The power of partnership – the unique alliance taking on brain cancer

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

15 December 2022

• For Supporters

The Taylor Family Foundation gives £2.1m to support head and neck cancer research

12 December 2022

• Health & Medicine
• Policy & Insight

The 10-year cancer plan: is improving cancer survival still a priority for this Government?  

Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer. Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer.

8 December 2022

• Health & Medicine
• Charity News

20 years of Cancer Research UK: Celebrating our research nurses

As part of our 20th anniversary we're celebrating our research nurses, who play a vital role in making sure patients are safe and cared for in clinical trials. As part of our 20th anniversary we're celebrating our research nurses, who play a vital role in making sure patients are safe and cared for in clinical trials.

7 December 2022

• Health & Medicine

First-of-its-kind app for patients on clinical trials being piloted by Cancer Research UK

Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.   Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.  

28 November 2022

• Policy & Insight
• Health & Medicine

How targeted screening can help the NHS save lives from lung cancer, the UK's leading cause of cancer death

Finding lung cancer early makes it much easier to treat. Dr Samantha Quaife, an expert in lung screening, explains how it can save lives and fight inequality. Finding lung cancer early makes it much easier to treat. Dr Samantha Quaife, an expert in lung screening, explains how it can save lives and fight inequality.

23 November 2022

• For Researchers

Thinking outside the chromosome – how ecDNA is challenging conventional thinking

What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study? What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study?

11 November 2022

• Health & Medicine
• Science & Technology

Repurposing radiotherapy drugs could give immunotherapy a boost

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

11 November 2022

• Science & Technology

Stopping the spread: A revolution in how we think about metastasis

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

18 October 2022